Matuszewski Jason
Chief Executive Officer
Matuszewski Jason has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Nov 19, 2026.
On the most recent filing, Matuszewski Jason is listed as Chief Executive Officer at BioStem Technologies, Inc. Inside the rolling window, Matuszewski Jason reported no open-market purchases and 1 open-market sale totaling $14K in BSEM.
Companies traded
Other insiders at BSEM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$14K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Matuszewski Jason made?
Matuszewski Jason has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Matuszewski Jason trade?
Matuszewski Jason has filed SEC Form 4 disclosures for 1 company, including BSEM.
When was Matuszewski Jason's most recent SEC Form 4 filing?
Matuszewski Jason's most recent SEC Form 4 filing on Tracefour is dated Nov 19, 2026.
What is Matuszewski Jason's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Matuszewski Jason is listed as Chief Executive Officer.
What is Matuszewski Jason's total buy and sell value in the current window?
Inside the rolling retention window, Matuszewski Jason bought $0 and sold $14K based on SEC Form 4 filings.
What was Matuszewski Jason's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 14,300 BSEM shares on 2026-11-17, worth $14K, per SEC Form 4 filings.